dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Arrambide García, Georgina |
dc.contributor.author | Llaneza González, Miguel Ángel |
dc.contributor.author | Fernández-Díaz, Eva |
dc.contributor.author | Moreno Torres, Irene |
dc.contributor.author | Meca-Lallana, Virginia |
dc.contributor.author | Costa-Frossard França, Lucienne |
dc.date.accessioned | 2022-04-06T06:38:46Z |
dc.date.available | 2022-04-06T06:38:46Z |
dc.date.issued | 2021-06-24 |
dc.identifier.citation | Arrambide G, Llaneza-González MA, Costa-Frossard França L, Meca-Lallana V, Díaz EF, Moreno-Torres I, et al. SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry. Neurol Neuroimmunol Neuroinflamm. 2021 Jun 24;8(5):e1024. |
dc.identifier.issn | 2332-7812 |
dc.identifier.uri | https://hdl.handle.net/11351/7306 |
dc.description | Esclerosis múltiple; Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV |
dc.language.iso | eng |
dc.publisher | Lippincott Williams & Wilkins |
dc.relation.ispartofseries | Neurology® neuroimmunology & neuroinflammation;8(5) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Esclerosi múltiple - Tractament |
dc.subject | Medicaments immunosupressors - Ús terapèutic - Efectes secundaris |
dc.subject | COVID-19 (Malaltia) - Epidemiologia |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Multiple Sclerosis |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Immunosuppressive Agents |
dc.title | SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1212/NXI.0000000000001024 |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | esclerosis múltiple |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | inmunosupresores |
dc.relation.publishversion | https://doi.org/10.1212/NXI.0000000000001024 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Arrambide G] Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Llaneza-González MA] Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain. [Costa-Frossard França L] Hospital Universitario Ramón y Cajal, Madrid, Spain. [Meca-Lallana V] Hospital Universitario de la Princesa, Madrid, Spain. [Díaz EF] Complejo Hospitalario Universitario de Albacete, Albacete, Spain. [Moreno-Torres I] Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain |
dc.identifier.pmid | 34168057 |
dc.identifier.wos | 000711825500024 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |